Administration of low intensity vibration and a RANKL inhibitor, alone or in combination, reduces bone loss after spinal cord injury-induced immobilization in rats

Authors: Yuanzhen Peng, Helen M. Bramlett, W. Dalton Dietrich, Alex Marcillo, Juliana Sanchez-Molano, Ofelia Furones-Alonso, Jay J. Cao, Jenney Huang, Andrew A. Li, Jian Q. Feng, William A. Bauman, Weiping Qin

Source: Bone Reports, Vol 23, Iss , Pp 101808- (2024)

Subject Terms: Immobilization, Spinal cord injury, Low intensity vibration, RANKL inhibitor, Bone resorption, Bone formation, Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2352187224000755; https://doaj.org/toc/2352-1872

Access URL: https://doaj.org/article/d83b87086c9640078c1c19b0393202c4

Beyond Bone Remodeling: Denosumab’s Multisystemic Benefits in Musculoskeletal Health, Metabolism, and Age-Related Diseases—A Narrative Review

Authors: Yi-Ting Hung, Wen-Tien Wu, Ru-Ping Lee, Ting-Kuo Yao, Kuang-Ting Yeh

Source: Biomedicines, Vol 13, Iss 3, p 732 (2025)

Subject Terms: osteoporosis, sarcopenia, osteosarcopenia denosumab, RANKL inhibitor, RANK/RANKL/OPG pathway (RRO pathway), Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://www.mdpi.com/2227-9059/13/3/732; https://doaj.org/toc/2227-9059

Access URL: https://doaj.org/article/08d03e96d9644eb4b23eb512bf32ba87

A Comparison of the Efficacy and Safety of Denosumab and Zoledronic Acid in Patients with Bone Metastatic Breast Cancer Receiving CDK4/6 Inhibitor Therapy

Authors: İrem Öner, Hicran Anık, Bediz Kurt İnci, Pınar Kubilay Tolunay, Öztürk Ateş, Ülkü Yalçıntaş Arslan, Cengiz Karaçin

Source: Medicina, Vol 61, Iss 2, p 360 (2025)

Subject Terms: cdk4/6 inhibitor, ribociclib, palbociclib, denosumab, RANKL inhibitor, zoledronic acid, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.mdpi.com/1648-9144/61/2/360; https://doaj.org/toc/1010-660X; https://doaj.org/toc/1648-9144

Access URL: https://doaj.org/article/137331ebf21a49d8b43c46c6f6ecdcbc

Denosumab Treatment Does Not Halt Progression of Bone Lesions in Multicentric Carpotarsal Osteolysis Syndrome

Authors: Melissa A. Lerman, Michael Francavilla, Lindsay Waqar‐Cowles, Michael A. Levine

Source: JBMR Plus, Vol 7, Iss 5, Pp n/a-n/a (2023)

Subject Terms: DENOSUMAB, MafB, MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME, RANKL‐INHIBITOR, Orthopedic surgery, RD701-811, Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: https://doaj.org/toc/2473-4039

Access URL: https://doaj.org/article/34218c8aa46340a7b5f67b0eb2cd370e

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.